{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T20:11:00Z","timestamp":1770667860344,"version":"3.49.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive Toxicology"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.reprotox.2020.05.008","type":"journal-article","created":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T12:55:47Z","timestamp":1589979347000},"page":"86-94","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Role of Cbp, p300 and Akt in valproic acid induced neural tube defects in CD-1 mouse embryos"],"prefix":"10.1016","volume":"95","author":[{"given":"Sidra","family":"Shafique","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise M.","family":"Winn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.reprotox.2020.05.008_bib0005","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0197-0186(00)00013-9","article-title":"Mechanisms of action of valproate: a commentatory","volume":"37","author":"Johannessen","year":"2000","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.reprotox.2020.05.008_bib0010","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2165\/00023210-200216100-00003","article-title":"Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy","volume":"16","author":"Loscher","year":"2002","journal-title":"CNS Drugs"},{"issue":"Suppl 6","key":"10.1016\/j.reprotox.2020.05.008_bib0015","first-page":"9","article-title":"Treatment of bipolar disorder","volume":"64","author":"M\u00f6ller","year":"2003","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.reprotox.2020.05.008_bib0020","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0022-3476(80)80517-8","article-title":"Teratogenicity of valproic acid","volume":"97","author":"Dalens","year":"1980","journal-title":"J. Pediatr."},{"key":"10.1016\/j.reprotox.2020.05.008_bib0025","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S1474-4422(05)70224-6","article-title":"Birth defects after prenatal exposure to antiepileptic drugs","volume":"4","author":"Perucca","year":"2005","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.reprotox.2020.05.008_bib0030","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1741-4520.2006.00104.x","article-title":"Etiology, pathogenesis and prevention of neural tube defects","volume":"46","author":"Padmanabhan","year":"2006","journal-title":"Congenit. Anom. (Kyoto)."},{"key":"10.1016\/j.reprotox.2020.05.008_bib0035","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/path.2643","article-title":"Genetics and development of neural tube defects","volume":"220","author":"Copp","year":"2010","journal-title":"J. Pathol."},{"key":"10.1016\/j.reprotox.2020.05.008_bib0040","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0041-008X(85)90081-X","article-title":"Teratogenic valproic acid concentrations: infusion by implanted minipumps vs conventional injection regimen in the mouse","volume":"80","author":"Nau","year":"1985","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.reprotox.2020.05.008_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.reprotox.2009.02.014","article-title":"Valproic acid in pregnancy: How much are we endangering the embryo and fetus?","volume":"28","author":"Ornoy","year":"2009","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.reprotox.2020.05.008_bib0050","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1146\/annurev-genet-120213-092208","article-title":"Genetic, epigenetic, and environmental contributions to neural tube closure","volume":"48","author":"Wilde","year":"2014","journal-title":"Annu. Rev. Genet."},{"key":"10.1016\/j.reprotox.2020.05.008_bib0055","doi-asserted-by":"crossref","first-page":"36734","DOI":"10.1074\/jbc.M101287200","article-title":"Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen","volume":"276","author":"Phiel","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.reprotox.2020.05.008_bib0060","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","article-title":"Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells","volume":"20","author":"G\u00f6ttlicher","year":"2001","journal-title":"Embo J."},{"key":"10.1016\/j.reprotox.2020.05.008_bib0065","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.taap.2010.08.001","article-title":"Epigenetic modifications in valproic acid-induced teratogenesis","volume":"248","author":"Tung","year":"2010","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.reprotox.2020.05.008_bib0070","doi-asserted-by":"crossref","DOI":"10.1186\/s13072-015-0021-9","article-title":"Cells adapt to the epigenomic disruption caused by histone deacetylase inhibitors through a coordinated, chromatin-mediated transcriptional response","volume":"8","author":"Halsall","year":"2015","journal-title":"Epigenetics Chromatin"},{"key":"10.1016\/j.reprotox.2020.05.008_bib0075","doi-asserted-by":"crossref","first-page":"5396","DOI":"10.1093\/nar\/gkq184","article-title":"Genome-wide assessment of differential roles for p300 and CBP in transcription regulation","volume":"38","author":"Ramos","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.reprotox.2020.05.008_bib0080","doi-asserted-by":"crossref","first-page":"13505","DOI":"10.1074\/jbc.R000025200","article-title":"CREB-binding protein and p300 in transcriptional regulation","volume":"276","author":"Vo","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.reprotox.2020.05.008_bib0085","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3389\/fnmol.2018.00255","article-title":"cAMP response element-binding protein (CREB): a possible signaling molecule link in the pathophysiology of schizophrenia","volume":"11","author":"Wang","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.reprotox.2020.05.008_bib0090","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0092-8674(00)82001-2","article-title":"The transcriptional coactivators p300 and CBP are histone acetyltransferases","volume":"87","author":"Ogryzko","year":"1996","journal-title":"Cell."},{"key":"10.1016\/j.reprotox.2020.05.008_bib0095","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0092-8674(00)81165-4","article-title":"Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300","volume":"93","author":"Yao","year":"1998","journal-title":"Cell."},{"key":"10.1016\/j.reprotox.2020.05.008_bib0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/951724","article-title":"Akt: A double-edged sword in cell proliferation and genome stability","volume":"2012","author":"Xu","year":"2012","journal-title":"J. Oncol."},{"key":"10.1016\/j.reprotox.2020.05.008_bib0105","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1038\/sj.onc.1201750","article-title":"Akt2 mRNA is highly expressed in embryonic brown fat and the AKT2 kinase is activated by insulin","volume":"16","author":"Altomare","year":"1998","journal-title":"Oncogene."},{"key":"10.1016\/j.reprotox.2020.05.008_bib0110","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1101\/gad.913901","article-title":"Growth retardation and increased apoptosis in mice with homozygous disruption of the akt1 gene","volume":"15","author":"Chen","year":"2001","journal-title":"Genes Dev."},{"key":"10.1016\/j.reprotox.2020.05.008_bib0115","doi-asserted-by":"crossref","first-page":"31359","DOI":"10.1016\/S0021-9258(19)84048-6","article-title":"Suberoylanilide hydroxamic acid induces Akt-mediated phosphorylation of p300, which promotes acetylation and transcriptional activation of RelA\/p65","volume":"281","author":"Liu","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.reprotox.2020.05.008_bib0120","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1124\/mol.111.072314","article-title":"Valproic acid increases formation of reactive oxygen species and induces apoptosis in postimplantation embryos: a role for oxidative stress in valproic acid-induced neural tube defects","volume":"80","author":"Tung","year":"2011","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.reprotox.2020.05.008_bib0125","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/toxsci\/kfu105","article-title":"Tissue-specific effects of valproic acid on DNA repair genes and apoptosis in postimplantation mouse embryos","volume":"141","author":"Lamparter","year":"2014","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.reprotox.2020.05.008_bib0130","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2-\u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods."},{"key":"10.1016\/j.reprotox.2020.05.008_bib0135","doi-asserted-by":"crossref","first-page":"5714","DOI":"10.1038\/sj.onc.1202930","article-title":"Function for p300 and not CBP in the apoptotic response to DNA damage","volume":"18","author":"Yuan","year":"1999","journal-title":"Oncogene."},{"key":"10.1016\/j.reprotox.2020.05.008_bib0140","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.taap.2016.07.001","article-title":"Valproic acid exposure decreases Cbp\/p300 protein expression and histone acetyltransferase activity in P19 cells","volume":"306","author":"Lamparter","year":"2016","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.reprotox.2020.05.008_bib0145","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.taap.2005.07.008","article-title":"Folic acid and pantothenic acid protection against valproic acid-induced neural tube defects in CD-1 mice","volume":"211","author":"Dawson","year":"2006","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.reprotox.2020.05.008_bib0150","first-page":"1303","article-title":"Valproic acid-induced fetal malformations are reduced by maternal immune stimulation with granulocyte-macrophage colony- stimulating factor or interferon-gamma","volume":"288","author":"Hrubec","year":"2008","journal-title":"Anat. Rec. A. Discov. Mol. Cell. Evol. Biol."},{"key":"10.1016\/j.reprotox.2020.05.008_bib0155","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/00001622-200111000-00010","article-title":"Histone deacetylase inhibitors as new cancer drugs","volume":"13","author":"a Marks","year":"2001","journal-title":"Curr. Opin. Oncol."},{"issue":"19-20","key":"10.1016\/j.reprotox.2020.05.008_bib0160","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.drudis.2009.06.008","article-title":"Histone acetyl transferases as emerging drug targets","volume":"14","author":"Dekker","year":"2009","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.reprotox.2020.05.008_bib0165","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1128\/MCB.00066-07","article-title":"Loss of Gcn5 acetyltransferase activity leads to neural tube closure defects and exencephaly in mouse embryos","volume":"27","author":"Bu","year":"2007","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.reprotox.2020.05.008_bib0170","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/jnci\/djs648","article-title":"PKB\/akt-dependent regulation of cell motility","volume":"105","author":"Xue","year":"2013","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.reprotox.2020.05.008_bib0175","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1093\/nar\/gks1312","article-title":"P38 MAPK- and Akt-mediated p300 phosphorylation regulates its degradation to facilitate nucleotide excision repair","volume":"41","author":"Wang","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.reprotox.2020.05.008_bib0180","first-page":"1","article-title":"Signaling in cell differentiation and morphogenesis","volume":"4","author":"Albert Basson","year":"2012","journal-title":"Cold Spring Harb. Perspect. Biol. Med."},{"key":"10.1016\/j.reprotox.2020.05.008_bib0185","doi-asserted-by":"crossref","first-page":"10407","DOI":"10.1128\/MCB.25.23.10407-10418.2005","article-title":"Dosage-dependent effects of Akt1\/Protein kinase B (PKB) and Akt3\/PKB on Thymus, skin, and cardiovascular and nervous system development in mice","volume":"25","author":"Yang","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.reprotox.2020.05.008_bib0190","first-page":"1","article-title":"Early behavioral abnormalities and perinatal alterations of PTEN\/AKT pathway in valproic acid autism model mice","volume":"11","author":"Yang","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.reprotox.2020.05.008_bib0195","doi-asserted-by":"crossref","first-page":"j4426","DOI":"10.1136\/bmj.j4426","article-title":"Women still not being told about pregnancy risks of valproate","volume":"358","author":"Wise","year":"2017","journal-title":"BMJ."}],"container-title":["Reproductive Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623820301362?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623820301362?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:51:43Z","timestamp":1760190703000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890623820301362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":39,"alternative-id":["S0890623820301362"],"URL":"https:\/\/doi.org\/10.1016\/j.reprotox.2020.05.008","relation":{},"ISSN":["0890-6238"],"issn-type":[{"value":"0890-6238","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of Cbp, p300 and Akt in valproic acid induced neural tube defects in CD-1 mouse embryos","name":"articletitle","label":"Article Title"},{"value":"Reproductive Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reprotox.2020.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}